DK0479631T3 - Derivater af spiro(4.5)decan, fremgangsmåde til deres fremstilling og farmaceutiske præparater indeholdende sådanne derivater - Google Patents

Derivater af spiro(4.5)decan, fremgangsmåde til deres fremstilling og farmaceutiske præparater indeholdende sådanne derivater

Info

Publication number
DK0479631T3
DK0479631T3 DK91402373.4T DK91402373T DK0479631T3 DK 0479631 T3 DK0479631 T3 DK 0479631T3 DK 91402373 T DK91402373 T DK 91402373T DK 0479631 T3 DK0479631 T3 DK 0479631T3
Authority
DK
Denmark
Prior art keywords
derivatives
decane
spiro
preparation
pharmaceutical preparations
Prior art date
Application number
DK91402373.4T
Other languages
Danish (da)
English (en)
Inventor
Gilbert Regnier
Claude Guillonneau
Jean-Paul Vilaine
Albert Lenaers
Jean-Pierre Iliou
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Application granted granted Critical
Publication of DK0479631T3 publication Critical patent/DK0479631T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK91402373.4T 1990-09-06 1991-09-05 Derivater af spiro(4.5)decan, fremgangsmåde til deres fremstilling og farmaceutiske præparater indeholdende sådanne derivater DK0479631T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR909011044A FR2666583B1 (fr) 1990-09-06 1990-09-06 Nouveaux derives du spiro [4.5] decane, leur procede de preparation et leurs compositions pharmaceutiques les renfermant.

Publications (1)

Publication Number Publication Date
DK0479631T3 true DK0479631T3 (da) 1995-04-10

Family

ID=9400108

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91402373.4T DK0479631T3 (da) 1990-09-06 1991-09-05 Derivater af spiro(4.5)decan, fremgangsmåde til deres fremstilling og farmaceutiske præparater indeholdende sådanne derivater

Country Status (14)

Country Link
US (1) US5206247A (de)
EP (1) EP0479631B1 (de)
JP (1) JPH0786106B2 (de)
AT (1) ATE113595T1 (de)
AU (1) AU638354B2 (de)
CA (1) CA2050730A1 (de)
DE (1) DE69104948T2 (de)
DK (1) DK0479631T3 (de)
ES (1) ES2066390T3 (de)
FR (1) FR2666583B1 (de)
IE (1) IE66024B1 (de)
NZ (1) NZ239677A (de)
PT (1) PT98871A (de)
ZA (1) ZA917107B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5635514A (en) * 1994-10-25 1997-06-03 G. D. Searle & Company Heteroaralkyl and heteroarylthioalkyl thiophenolic compounds as 5-lipoxgenase inhibitors
FR2734265B1 (fr) * 1995-05-17 1997-06-13 Adir Nouveaux composes spiro heterocycliques, leur procede de preparation et les compositions pharmaceutiques les contenant
EA009987B1 (ru) * 1997-05-14 2008-04-28 Атеродженикс, Инк. Производные пробукола для лечения заболеваний, опосредованных vcam-1
US6852878B2 (en) * 1998-05-14 2005-02-08 Atherogenics, Inc. Thioketals and thioethers for inhibiting the expression of VCAM-1
US6670398B2 (en) * 1997-05-14 2003-12-30 Atherogenics, Inc. Compounds and methods for treating transplant rejection
EA200000087A1 (ru) 1997-07-01 2000-08-28 Атеродженикс, Инк. Повышение эффективности терапии гиперпролиферативных состояний с помощью антиоксиданта
WO2002087556A2 (en) * 2001-04-11 2002-11-07 Atherogenics, Inc. Probucol monoesters and their use to increase plasma hdl cholesterol levels and improve hdl functionality
AU2003266165A1 (en) * 2002-09-13 2004-04-30 Hossein Dovlatabadi Methods and compositons for the use of d-malic acid to decrease serum triglyceride, cholesterol, and lipoprotein levels
CN100548950C (zh) * 2003-01-13 2009-10-14 阿特罗吉尼克斯公司 制备普罗布考及其衍生物的酯和醚的方法
WO2005102323A2 (en) 2004-04-20 2005-11-03 Atherogenics, Inc. Process of preparing esters and ethers of probucol and derivatives thereof
WO2005112914A2 (en) 2004-04-20 2005-12-01 Atherogenics, Inc. Phenolic antioxidants for the treatment of disorders including arthritis, asthma and coronary artery disease
US8252840B2 (en) * 2007-03-26 2012-08-28 Salutria Pharmaceuticals Llc Methods of derivatives of probucol for the treatment of type II diabetes
US20080280985A1 (en) * 2007-03-27 2008-11-13 Scott Robert A D Methods and Compositions Using Certain Phenolic Derivatives for the Treatment of Diabetes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL127065C (de) * 1964-04-22
GB1478932A (en) * 1975-03-06 1977-07-06 Science Union & Cie 8-(3-chromanyl)-1-oxa-3,8-diazaspiro(4,5)decan-2-ones and thiones
US4244961A (en) * 1978-10-26 1981-01-13 Syntex (U.S.A.) Inc. 1-Oxa-3,8-diazaspiro[4.5]decan-2-ones antihypertensive agents
FR2615515B1 (fr) * 1987-05-22 1989-06-30 Adir Nouveaux derives du spiro 4, 5 decane, leur procede de preparation et les compositions pharmaceutiques les renfermant

Also Published As

Publication number Publication date
IE66024B1 (en) 1995-11-29
NZ239677A (en) 1992-10-28
AU638354B2 (en) 1993-06-24
ES2066390T3 (es) 1995-03-01
DE69104948T2 (de) 1995-06-08
ZA917107B (en) 1992-05-27
EP0479631B1 (de) 1994-11-02
JPH0786106B2 (ja) 1995-09-20
FR2666583B1 (fr) 1994-09-09
EP0479631A1 (de) 1992-04-08
IE913131A1 (en) 1992-03-11
PT98871A (pt) 1992-07-31
JPH04247082A (ja) 1992-09-03
FR2666583A1 (fr) 1992-03-13
ATE113595T1 (de) 1994-11-15
CA2050730A1 (fr) 1992-03-07
US5206247A (en) 1993-04-27
AU8369491A (en) 1992-03-12
DE69104948D1 (de) 1994-12-08

Similar Documents

Publication Publication Date Title
DE3365772D1 (en) 1,4-dihydropyridines, process for their preparation and their application as pharmaceutical preparations
DK0479631T3 (da) Derivater af spiro(4.5)decan, fremgangsmåde til deres fremstilling og farmaceutiske præparater indeholdende sådanne derivater
NO870241D0 (no) Hypoglykemiske tiazolidindioner.
ZA895090B (en) Novel benzopyran derivatives,processes for their preparation and their use and preparations containing the compounds
DK499088D0 (da) 1-oe(2-pyrimidinyl)-aminoalkylaapiperidinderivater, fremgangsmaade til fremstilling deraf og laegemiddel indeholdende saadanne derivater
DK400681A (da) Isoquinolinderivater fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse forbindelser og deres anvendelse
EP0486386A3 (en) Novel derivatives of n-benzoylproline, process for their preparation and drugs containing them
DK408083D0 (da) Isoquinilinderivater, deres fremstilling og anvendelse
NO840526L (no) Derivater av n-iminopyridiniumbetainer, fremgangsmaate til deres fremstilling og deres anvendelse i medikamenter
FI902901A0 (fi) Dibenzol/1,5/dioxocin-5-one-derivat, deras anvaendning i laekemedel och foerfarande foer deras framstaellning.
DK601888A (da) Anvendelse af 2-pyrimidinyl-1-piperazinderivater
NO872574D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydro-benzotiazoler.
DE3378120D1 (en) Thiazaspiro derivatives, process for their preparation and pharmaceutical composition
DK73289A (da) Basisk substituerede 5-halogen-thienoisothiazol-3(2h)-on-1,1-dioxider, fremgangsmaade til fremstilling af saadanne forbindelser og farmaceutiske praeparater indeholdende disse
GR860679B (en) Novel 3-pyridylmethylnaphthyl derivatives method for their preparation and their use as medicine
DK222588D0 (da) 5-quinoxalyl-imidazolidin-2,4-dioner, deres fremstilling og anvendelse som laegemidler
ES2064948T3 (es) Polimetilen-iminas disustituidas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
DK423289A (da) Sulfonamider med tetrazolylrest, fremgangsmaade til deres fremstilling samt laegemiddel
SE9203824L (sv) Bensofuranylimidazol-derivat, foerfarande foer framstaellning daerav och terapeutiska kompositioner innehaallande desamma
DK364386D0 (da) 1-alkyl-ergolinyl-thiourinstofderivater og fremgangsmaade til fremstilling deraf samt deres anvendelse
DE3684867D1 (de) 5-aminopentanitrilderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
DK631188D0 (da) Substituerede thienoimidazol-derivater, deres fremstiling og anvendelse
SE9002508D0 (sv) Asymmetric synthesis of furo (3,4-c) pyridine derivatives